Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
7,363,810
-
Share change
-
+2,172,041
-
Total reported value
-
$3,069,168
-
Price per share
-
$0.42
-
Number of holders
-
29
-
Value change
-
+$954,989
-
Number of buys
-
20
-
Number of sells
-
9
Institutional Holders of BIOLASE INC - COM NEW (BIOL) as of Q4 2020
As of 31 Dec 2020,
BIOLASE INC - COM NEW (BIOL) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,363,810 shares.
The largest 10 holders included
ORACLE INVESTMENT MANAGEMENT INC, VANGUARD GROUP INC, PERKINS CAPITAL MANAGEMENT INC, Invenomic Capital Management LP, Squarepoint Ops LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., GSA CAPITAL PARTNERS LLP, RENAISSANCE TECHNOLOGIES LLC, and WHITE PINE CAPITAL LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.